Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database

Andrea Ferrari, Iyad Sultan, Tseng Tien Huang, Carlos Rodriguez-Galindo, Ahmad Shehadeh, Cristina Meazza, Kirsten K. Ness, Michela Casanova, Sheri L. Spunt

Research output: Contribution to journalArticle

Abstract

Background: Soft tissue sarcomas (STS) are a heterogeneous group of mesenchymal malignancies that occur throughout the lifespan. The impact of age on disease features and outcome is unclear. Methods: We analyzed the clinical features and outcome of all STS cases registered between 1973 and 2006 in the SEER database. Results: There were 48,012 cases that met the selection criteria. Individuals less than 20 years of age represented 5.6%, with rhabdomyosarcoma being the most common subtype. In adults, the most common types were Kaposi sarcoma, fibrohistiocytic tumors, and leiomyosarcoma. Rhabdomyosarcoma was the only entity with a median age

Original languageEnglish
Pages (from-to)943-949
Number of pages7
JournalPediatric Blood and Cancer
Volume57
Issue number6
DOIs
Publication statusPublished - Dec 1 2011

Keywords

  • Age
  • Epidemiology
  • Prognosis
  • SEER
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Fingerprint Dive into the research topics of 'Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database'. Together they form a unique fingerprint.

  • Cite this